https://platoaistream.com/plato-data/sinomab-dosed-first-healthy-subject-in-phase-i-clinical-trial-of-sm17-in-the-u-s/
SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.